World /

COVID-19: Lilly antibody treatment trial paused over safety concern

Pharma giant pauses late-stage trial of experimental lab-produced antibody treatment

Last updated: October 14, 2020 | 02:41

AFP

1 MIN READ

Add as a preferred source on Google

Shutterstock

Also In This Package

Half of Chinese city of 9m swabbed for COVID in 2 days

Photos: Nearly half of Chinese city of 9 million swabbed for COVID-19 in two days

Dead, ill, recovered: Celebrities hit by COVID-19

Cafe hits sweet spot with virus-shaped dessert

Photos: Prague cafe hits sweet spot with coronavirus-shaped dessert

Trump resumes campaign after bout with COVID-19

Washington: US pharmaceutical firm Eli Lilly on Tuesday paused a late-stage trial of its experimental lab-produced antibody treatment against COVID-19 over an unspecified safety concern, the company said.

“Lilly is supportive of the decision by the independent DSMB (data safety monitoring board) to cautiously ensure the safety of the patients participating in this study,” a spokesperson said in a statement.

Related Stories

The US Navy destroyer USS Rafael Peralta refuels from the amphibious assault ship USS Tripoli during operations at sea. Amphibious ships like the Tripoli can deploy Marine Expeditionary Units during crises such as the current Iran war.

US deploys Marines as war shifts to Strait of Hormuz

25m ago3m read

Smoke rising from the Thai bulk carrier 'Mayuree Naree' near the Strait of Hormuz after an Iranian attack.

Two weeks on, Trump scrambles as Iran war escalates

5m read

Cubans go out on the streets to several nights of protest power outages, and an oil supply crunch, even as the Cuban leader confirmed historic talks with US to ease the trade embargo.

Cuba ignites: Furious protesters storm, torch party HQ

4m read

China's President Xi Jinping and US President Donald Trump.

Trump, Xi prepare to meet amid war, uncertain goals

3m read

COVID-19: Lilly antibody treatment trial paused over safety concern

Get Updates on Topics You Choose